Lymphoproliferative disorders of the gastrointestinal tract: A review and pragmatic guide to diagnosis

Archives of Pathology and Laboratory Medicine

Volumn 135, Issue 10, 2011, Pages 1283-1297

  Burke, Jerome S ^a  

^a ALTA BATES SUMMIT MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLASSIFICATION; DIFFERENTIAL DIAGNOSIS; ENTEROPATHY ASSOCIATED T CELL LYMPHOMA; GASTROINTESTINAL DISEASE; GASTROINTESTINAL TUMOR; GENE TRANSLOCATION; GENETICS; HUMAN; LARGE CELL LYMPHOMA; LYMPHOMA; LYMPHOPROLIFERATIVE DISEASE; MANTLE CELL LYMPHOMA; MARGINAL ZONE LYMPHOMA; PSEUDOLYMPHOMA; REVIEW;

DIAGNOSIS, DIFFERENTIAL; ENTEROPATHY-ASSOCIATED T-CELL LYMPHOMA; GASTROINTESTINAL DISEASES; GASTROINTESTINAL NEOPLASMS; HUMANS; LYMPHOMA; LYMPHOMA, B-CELL, MARGINAL ZONE; LYMPHOMA, LARGE B-CELL, DIFFUSE; LYMPHOMA, MANTLE-CELL; LYMPHOPROLIFERATIVE DISORDERS; PSEUDOLYMPHOMA; TRANSLOCATION, GENETIC;

EID: 80055075784     PISSN: 00039985     EISSN: 15432165     Source Type: Journal    
DOI: 10.5858/arpa.2011-0145-RA     Document Type: Review

References (135)

1. Graves FD, Linet MS, Travis LB, Devesa SS. Cancer surveillance series: non- Hodgkin's lymphoma incidence by histologic subtype in the United States from 1978 through 1995. ; Natl Cancer Inst. 2000;92(15):1240-1251. (Pubitemid 30627732)
2. Knowles DM, Chamulak GA, Subar M, et al. Lymphoid neoplasia associated with the acquired immunodeficiency syndrome (AIDS): the New York University Medical Center experience with 105 patients (1981-1986). Ann Intern Med. 1988;108(5):744-753.
3. Shepherd, NA, Hall PA, Coates PJ, Levison DA. Primary malignant lymphoma of the colon and rectum: a histopathological and immunohistochemical analysis of 45 cases with clinicopathological correlations. Histopathology. 1988;12(3):235-252.
4. Askling J, Brandt L, Lapidus A, et al. Risk of haematopoietic cancer in patients with inflammatory bowel disease. Gut. 2005:54(5):617-622. (Pubitemid 40559243)
5. Koch P, del Valle F, Berdel W, et al. Primary gastrointestinal non-Hodgkin's lymphoma, I: anatomic and histologic distribution, clinical features, and survival data of 371 patients registered in the German multicenter study GIT NHL 01/92. ; Clin Oncol. 2001;19(18):3861-3873. (Pubitemid 32880065)
6. Luminari S, Cesaretti M, Marcheselli L, et al. Decreasing incidence of gastric MALT lymphomas in the era of anti-Helicobacter pylori interventions: results from a population-based study on extranodal marginal zone lymphomas. Ann Oncol. 2010;21(4):855-859.
7. Isaacson P, Wright DH. Malignant lymphoma of mucosa-associated lymphoid tissue: a distinctive type of B-cell lymphoma. Cancer. 1983;52(8):1410-1416. (Pubitemid 13017202)
8. Isaacson P, Wright DH. Extranodal malignant lymphoma arising from mucosa-associated lymphoid tissue. Cancer. 1984;53(11):2515-2524. (Pubitemid 14102496)
9. Isaacson PG, Spencer J. Malignant lymphoma of mucosa-associated lymphoid tissue. Histopathology. 1987;11(5):445-462. (Pubitemid 17079432)
10. Isaacson PG. Lymphomas of mucosa-associated lymphoid tissue (MALT). Histopathology. 1990;16(6):617-619. (Pubitemid 20183017)
11. Isaacson PG, Wotherspoon AC, Pan L. Follicular colonization in B-cell lymphoma of mucosa-associated lymphoid tissue. Am J Surg Pathol. 1991;15(9): 819-828.
12. Wotherspoon AC, Doglioni C, Diss TC, et al. Regression of primary lowgrade B-cell gastric lymphoma of mucosa-associated lymphoid tissue type after eradication of Helicobacter pylori. Lancet. 1993;342(8871):575-577. (Pubitemid 23259233)
13. Du M, Diss TC, Xu C, Peng H, Isaacson PG, Pan L. Ongoing mutation in MALT lymphoma immunoglobulin gene suggests that antigen stimulation plays a role in the clonal expansion. Leukemia. 1996;10(7):1190-1197. (Pubitemid 26254025)
14. Wotherspoon AC, Finn TM, Isaacson PG. Trisomy 3 in low-grade B-cell lymphomas of mucosa-associated lymphoid tissue. Blood. 1995;85(8):2000-2004.
15. Auer IA, Gascoyne RD, Connors JM, et al. t(11;18)(q21;q21) is the most common translocation in MALT lymphomas. Ann Oncol. 1997;8(10):979-985. (Pubitemid 27475729)
16. Liu H, Ye H, Dogan A, et al. t(11;18)(q21;q21) is associated with advanced mucosa-associated lymphoid tissue lymphoma that expresses nuclear BCL10. Blood. 2001 ;98(4): 1182-1187.
17. Remstein ED, Dogan A, Einerson RR, et al. The incidence and anatomic site specificity of chromosomal translocations in primary extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma) in North America. Am J Surg Pathol. 2006;30(12):1546-1553. (Pubitemid 44815508)
18. Zucca E, Bertoni F, Roggero E, Cavalli F. The gastric marginal zone B-cell lymphoma of MALT type. Blood. 2000;96(2):410-419. (Pubitemid 30463357)
19. Isaacson PG, Du MQ. MALT lymphoma: from morphology to molecules. Nat Rev Cancer. 2004;4(8):644-653. (Pubitemid 39025059)
20. Isaacson PG, Du MQ. Gastrointestinal lymphoma: where morphology meets molecular biology. J Pathol. 2005;205(2);255-274. (Pubitemid 40227996)
21. Bacon CM, Du MQ, Dogan A. Mucosa-associated lymphoid tissue (MALT) lymphoma: a practical guide for pathologists. J Clin Pathol. 2007;60(4):361-372. (Pubitemid 46596553)
22. Burke JS. Extranodal hematopoietic/lymphoid disorders: an introduction. Am J Clin Pathol. 1999;111(suppl 1):S40-S45. (Pubitemid 29024948)
23. Saltzstein SL. Extranodal malignant lymphomas and pseudolymphomas. Pathol Annu. 1969;4:159-184.
24. Burke JS. Histologic criteria for distinguishing between benign and malignant extranodal lymphoid infiltrates. Semin Diagn Pathol. 1985;2(3):152-162. (Pubitemid 15235610)
25. Burke JS. Are there site-specific differences among the MALT lymphomas- morphologic, clinical? Am J Clin Pathol. 1999;11 (suppl 1):S133-S143. (Pubitemid 29024958)
26. Kurtin PJ. How do you distinguish benign from malignant extranodal small B-cell proliferations? Am J Clin Pathol. 1999;111 (suppl 1):S119-S126.
27. Abbondanzo SL, Sobin LH. Gastric "pseudolymphoma": a retrospective morphologic and immunophenotypic study of 97 cases. Cancer. 1997;79(9): 1656-1663. (Pubitemid 27176345)
28. Almasri NM, Zaer FS, Iturraspe JA, Braylan RC. Contribution of flow cytometry to the diagnosis of gastric lymphomas in endoscopic biopsy specimens. Mod Pathol. 1997;10(7):650-656. (Pubitemid 27321754)
29. Hsi ED, Greenson JK, Singleton TP, Siddiqui J, Schnitzer B, Ross CW. Detection of immunoglobulin heavy chain gene rearrangement by polymerase chain reaction in chronic active gastritis associated with Helicobacter pylori. Hum Pathol. 1996;27(3):290-296. (Pubitemid 26078910)
30. Wiindisch T, Neubauer A, Stolte M, Ritter M, Thiede C. B-cell monoclonality is associated with lymphoid follicles in gastritis. Am J Surg Pathol. 2003;27(7):882-887. (Pubitemid 36758890)
31. Carney JA. Gastric mucosal lymphoid follicles: histology, distribution, frequency, and etiologic features. Am J Surg Pathol. 2010;34(7):1019-1024.
32. Isaacson PG. Gastrointestinal lymphomas of T- and B-cell types. Mod Pathol. 1999;12(2):151-158. (Pubitemid 29093899)
33. Rubin A, Isaacson PG. Florid reactive lymphoid hyperplasia of the terminal ileum in adults: a condition bearing a close resemblance to low-grade malignant lymphoma. Histopathology. 1990;17(1):19-26. (Pubitemid 20225763)
34. Isaacson PG, Norton AJ. Extranodal Lymphomas. Edinburgh, Scotland: Churchill Livingstone; 1994.
35. Farris AB, Lauwers GY, Ferry JA, Zukerberg LR. The rectal tonsil: a reactive lymphoid proliferation that may mimic lymphoma. Am J Surg Pathol. 2008;32(7): 1075-1079.
36. Cramer SF, Romansky S, Hulbert B, Raugh S, Papp JR, Casiano-Colon AE. The rectal tonsil-a reaction to chlamydial infection (letter]? Am J Surg Pathol. 2009;33(3):483-485.
37. Isaacson PG, Chott A, Nakamura S, Miiller-Hermelink HK, Harris NL, Swerdlow SH. Extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma). In: Swedlow SH, Campo E, Harris NL, et al, eds. Haematopoietic and Lymphoid Tissues. Lyon, France: IARC Press; 2008:214-217. World Health Organization Classification of Tumours. 4th ed.
38. Isaacson PG, Chott A, Ott G, Stein H. Enteropathy-associated T-cell lymphoma. In: Swedlow SH, Campo E, Harris NL, et al, eds. Haematopoietic and Lymphoid Tissues. Lyon, France: IARC Press; 2008:289-291. World Health Organization Classification of Tumours. 4th ed.
39. Isaacson PG. Gastrointestinal lymphoma. Hum Pathol. 1994;25(10):1020- 1029. (Pubitemid 24313645)
40. Koch P, Probst A, Berdel W, et al. Treatment results in localized primary gastric lymphoma: data of patients registered within the German multicenter study (GIT NHL 02/96). J Clin Oncol. 2005;23(28):7050-7059.
41. Chan JK, Ng CS, Isaacson PG. Relationship between high-grade lymphoma and low-grade B-cell mucosa-associated lymphoid tissue lymphoma (MALToma) of the stomach. Am J Pathol. 1990;136(5):1153-1164. (Pubitemid 20188502)
42. Cogliatti SB, Schmid U, Schumacher U, et al. Primary B-cell gastric lymphoma: a clinicopathological study of 145 patients. Gastroenterology. 1991; 101 (5): 1159-1170.
43. Isaacson PG, Maclennan KA, Subbuswamy SG. Multiple lymphomatous polyposis of the gastrointestinal tract. Histopathology. 1994;8(4):641-656.
44. O'Briain DS, Kennedy MJ, Daly PA, et al. Multiple lymphomatous polyposis of the gastrointestinal tract: a clinicopathologically distinctive form of non-Hodgkin's lymphoma of B-cell centrocyte type. Am j Surg Pathol. 1989; 13(8):691-699. (Pubitemid 19185455)
45. Ruskone-Fourmestraux A, Audouin J. Primary gastrointestinal tract mantle cell lymphoma as multiple lymphomatous polyposis. Best Pract Res Clin Gastroenterol. 2010;24(1):35-42.
46. Moynihan MJ, Bast MA, Chan WC, et al. Lymphomatous polyposis: a neoplasm of either follicular mantle or germinal center cell origin. Am J Surg Pathol. 1996;20(4):442-452. (Pubitemid 26113350)
47. Kumar S, Krenacs L, Otsuki T, et al. bc/-1 rearrangement and cyclin D1 protein expression in multiple lymphomatous polyposis. Am J Clin Pathol. 1996; 105(6):737-743. (Pubitemid 26178720)
48. Kodama T, Ohshima K, Nomura K, et al. Lymphomatous polyposis of the gastrointestinal tract, including mantle cell lymphoma, follicular lymphoma and mucosa-associated lymphoid tissue lymphoma. Histopathology. 2005;47(5):467-478. (Pubitemid 41626724)
49. Geissmann F, Ruskone-Fourmestraux A, Hermine O, et al. Homing receptor a4B7 integrin expression predicts digestive tract involvement in mantle cell lymphoma. Am J Pathol. 1998;153(6):1701-1705. (Pubitemid 28550657)
50. Yatabe Y, Nakamura S, Nakamura T, et al. Multiple polypoid lesions of primary mucosa-associated lymphoid tissue lymphoma of colon. Histopathology. 1998;32(2):116-125. (Pubitemid 28126177)
51. Romaguera JE, Medeiros LJ, Hagemeister FB, et al. Frequency of gastrointestinal involvement and its clinical significance in mantle cell lymphoma. Cancer. 2003;97(3):586-691.
52. Salar A, Juanpere N, Bellosillo B, et al. Gastrointestinal involvement in mantle cell lymphoma: a prospective, clinic, endoscopic, and pathologic study. Am J Surg Pathol. 2006;30(10):1274-1280. (Pubitemid 44454707)
53. Yoshino T, Miyake K, Ichimura K, et al. Increased incidence of follicular lymphoma in the duodenum. Am J Surg Pathol. 2000;24(5):688-693. (Pubitemid 30253506)
54. Shia J, Teruya-Feldstein J, Pan D, et al. Primary follicular lymphoma of the gastrointestinal tract: a clinical and pathologic study of 26 cases. Am J Surg Pathol. 2002;26(2):216-224. (Pubitemid 34127501)
55. LeBrun DP, Kamel OW, Cleary ML, Dorfman RF, Warnke RA. Follicular lymphomas of the gastrointestinal tract: pathologic features in 31 cases and bcl-2 oncogenic protein expression. Am J Pathol. 1992;140(6):1327-1335.
56. Damaj G, Verkarre V, Delmer A, et al. Primary follicular lymphoma of the gastrointestinal tract: a study of 25 cases and a literature review. Ann Oncol. 2003;14(4):623-629. (Pubitemid 41295093)
57. Bende RJ, Smit LA, Bossenbroek JG, et al. Primary follicular lymphoma of the small intestine: α4B7 expression and immunoglobulin configuration suggest an origin from local antigen-presenting cells. Am J Pathol. 2003;162(1 ):105-113. (Pubitemid 36041993)
58. Sato Y, Ichimura K, Tanaka T, et al. Duodenal follicular lymphomas share common characteristics with mucosa-associated lymphoid tissue lymphomas. J Clin Pathol. 2008;61(3):377-381. (Pubitemid 351354249)
59. Takata K, Sato Y, Nakamura N, et al. Duodenal and nodal follicular lymphomas are distinct: the former lacks activation-induced cytidine deaminase and follicular dendritic cells despite ongoing somatic hypermutations. Mod Pathol. 2009;22(7):940-949.
60. Schmatz AI, Streubel B, Kretschmer-Chott E, et al. Primary follicular lymphoma of the duodenum is a distinct mucosal/submucosal variant of follicular lymphoma: a retrospective study of 63 cases. J Clin Oncol. 2011 ;29(11 ):1445-1451.
61. Galian A, Lecestre MJ, Scotto J, Bognel C, Matuchansky C, Rambaud JC. Pathological study of alpha-chain disease, with special emphasis on evolution. Cancer. 1977;39(5):2081-2101. (Pubitemid 8129046)
62. Lewin KJ, Kahn LB, Novis BH. Primary intestinal lymphoma of "Western" and "Mediterranean" type, alpha chain disease and massive plasma cell infiltration: a comparative study of 37 cases. Cancer. 1976;38(6):2511-2528. (Pubitemid 8015888)
63. Nassar VH, Salem PA, Shahid MJ, et al. Mediterranean abdominal lymphoma" or immunoproliferative small intestinal disease, part II: pathological aspects. Cancer. 1978;41(4):1340-1354. (Pubitemid 8330413)
64. Isaacson PG, Dogan A, Price SK, Spencer J. Immunoproliferative smallintestinal disease: an immunohistochemical study. Am J Surg Pathol. 1989; 13(12):1023-1033. (Pubitemid 20010987)
65. Al-Saleem T, Al-Mondhiry H. Immunoproliferative small intestinal disease (IPSID): a model for mature B-cell neoplasms. Blood. 2005;105(6):2274-2280. (Pubitemid 40387019)
66. Price SK. Immunoproliferative small intestinal disease: a study of 13 cases with alpha heavy-chain disease. Histopathology. 1990;17(1):7-17. (Pubitemid 20225762)
67. Lecuit M, Abachin E, Matin A, et al. Immunoproliferative small intestinal disease associated with Campylobacter jejuni. N Engl J Med. 2004;350(3):239-248. (Pubitemid 38067636)
68. Parsonnet J, Isaacson PG. Bacterial infection and MALT lymphoma. N Engl J Med. 2004;350(3):213-215. (Pubitemid 38067632)
69. Chott A, Dragosics B, Radaszkiewicz T. Peripheral T-cell lymphomas of the intestine. Am J Pathol. 1992;141(6):1361-1371. (Pubitemid 23002621)
70. Domizio P, Owen RA, Shepherd NA, Talbot IC, Norton AJ. Primary lymphoma of the small intestine: a clinicopathological study of 119 cases. Am J Surg Pathol. 1993;17(5):429-442. (Pubitemid 23121773)
71. Tokunaga O, Watanabe T, Shimamoto Y, Tokudome S. Primary T-cell lymphoma of the gastrointestinal tract associated with human T-cell lymphotropic virus type I: an analysis using in situ hybridization and polymerase chain reaction. Cancer. 1993;71(3):708-716. (Pubitemid 23051370)
72. Kohno S, Ohshima K, Yoneda S, Kodama T, Shirakusa T, Kikuchi M. Clinicopathological analysis of 143 primary malignant lymphomas in the small and large intestines based on the new WHO classification. Histopathology. 2003; 43(2):135-143. (Pubitemid 36963157)
73. TungCL, Hsieh PP, Chang JH, Chen RS, Chen YJ, WangJS. Intestinal T-cell and natural killer-cell lymphomas in Taiwan with special emphasis on 2 distinct cellular types: natural killer-like cytotoxic T cell and true natural killer cell. Hum Pathol. 2008;39(7):1018-1025.
74. Chuang SS, Chang ST, Chuang WY, et al. NK-cell lineage predicts poor survival in primary intestinal NK-cell and T-cell lymphomas. Am J Surg Pathol. 2009;33(8):1230-1240.
75. Ko YH, Karnan S, Kim KM, et al. Enteropathy-associated T-cell lymphoma-a clinicopathologic and array comparative genomic hybridization study. Hum Pathol. 2010;41(9):1231-1237.
76. Takeshita M, Nakamura S, Kikuma K, et al. Pathological and immunohistological findings and genetic aberrations of intestinal entropathy-associated T cell lymphoma in Japan. Histopathology. 2011;58(3):395-407.
77. Chott A, Vesely M, Simonitsch I, Mosberger I, Hanak H. Classification of intestinal T-cell neoplasms and their differential diagnosis. Am j Clin Pathol. 1999; 111 (suppl 1):S68-S74. (Pubitemid 29024951)
78. Chott A, Haedicke W, Mosberger I, et al. Most CD56* intestinal lymphomas are CD8*CD5 T-cell lymphomas of monomorphic small to medium size histology. Am J Pathol. 1998; 153(5): 1483-1490. (Pubitemid 28509905)
79. Bagdi E, Diss TC, Munson P, Isaacson PG. Mucosal intra-epithelial lymphocytes in enteropathy-associated T-cell lymphoma, ulcerative jejunitis, and refractory celiac disease constitute a neoplastic population. Blood. 1999;94(1): 260-264. (Pubitemid 29300157)
80. Zettl A, Ott G, Makulik A, et al. Chromosomal gains at 9q characterize enteropathy-type T-cell lymphoma. Am J Pathol. 2002;161 (5):1635-1645. (Pubitemid 35265523)
81. Zettl A, deLeeuw R, Haralambieva E, Mueller-Hermelink HK. Enteropathytype T-cell lymphoma. Am J Clin Pathol. 2007;127(5):701-706.
82. Deleeuw RJ, Zettl A, Klinker E, et al. Whole-genome analysis and HLA genotyping of enteropathy-type T-cell lymphoma reveals 2 distinct lymphoma subtypes. Gastroenterology. 2007;132(5):1902-1911. (Pubitemid 46677947)
83. Ashton-Key M, Diss TC, Pan L, Du MQ, Isaacson PC Molecular analysis of T-cell clonality in ulcerative jejunitis and enteropathy-associated T-cell lymphoma. Am J Pathol. 1997;151(2):493-498. (Pubitemid 27330068)
84. Cellier C, Delabesse E, Helmer C, et al. Refractory sprue, coeliac disease, and enteropathy-associated T-cell lymphoma. Lancet. 2000;356(9225):203-208. (Pubitemid 30446975)
85. de Mascarel A, Belleannée C, Stanislas S, et al. Mucosal intraepithelial Tlymphocytes in refractory celiac disease: a neoplastic population with a variable CD8 phenotype. Am J Surg Pathol. 2008;32(5):744-751. (Pubitemid 351600824)
86. Verkarre V, Romana SP, Cellier C, et al. Recurrent partial trisomy 1q22- q44 in clonal intraepithelial lymphocytes in refractory celiac sprue. Gastroenterology. 2003;125(1):40-46. (Pubitemid 36799105)
87. Carbonnel F, Grollet-Bioul L, Brouet JC, et al. Are complicated forms of celiac disease cryptic T-cell lymphomas? Blood. 1998;92(10):3879-3886. (Pubitemid 28525214)
88. Liu H, Bris R, Lavergne-Slove A, et al. Continual monitoring of intraepithelial lymphocyte immunophenotype and clonality is more important than snapshot analysis in the surveillance of refractory celiac disease. Gut 2010; 59(4):452-460.
89. Chan JKC, Sin VC, Wong KF, et al. Nonnasal lymphoma expressing the natural killer cell marker CD56: a clinicopathologic study of 49 cases of an uncommon aggressive neoplasm. Blood. 1997;89(12):4501-4513. (Pubitemid 27260260)
90. Ng SB, Lai KW, Murugaya S, et al. Nasal-type extranodal natural killer/ T-cell lymphomas: a clinicopathologic and genotypic study of 42 cases in Singapore. Mod Pathol. 2004;17(9):1097-1107. (Pubitemid 39128236)
91. Ko YH, Cho EY, Kim JE, et al. NK and NK-like T-cell lymphoma in extranasal sites: a comparative clinicopathological study according to site and EBV status. Histopathology. 2004;44(5):480-489. (Pubitemid 38725677)
92. Au WY, Weisenburger DD, Intragumtornchai T, et al. Clinical differences between nasal and extranasal natural killer/T-cell lymphoma: a study of 136 cases from the International Peripheral T-Cell Lymphoma Project. Blood. 2009; 113(17):3931-3937.
93. Daum S, Ullrich R, Heise W, et al. Intestinal non-Hodgkin's lymphoma: a multicenter prospective clinical study from the German Study Group on Intestinal Non-Hodgkin's Lymphoma. J Clin Oncol. 2003;21(14):2740-2746. (Pubitemid 46606320)
94. Mansoor A, Pittaluga S, Beck PL, Wilson WH, Ferry JA, Jaffe ES. NK-cell enteropathy: a benign NK-cell lymphoproliferative disease mimicking intestinal lymphoma-clinicopathological features and follow-up in a unique case series. Blood. 2011;117(5):1447-1452.
95. Takeuchi K, Yokoyama M, Ishizawa S, et al. Lymphomatoid gastropathy: a distinct clinicopathologic entity of self-limited pseudomalignant NK-cell proliferation. Blood. 2010;116(25):5631-5637.
96. Vega F, Chang CC, Schwartz MR, et al. Atypical NK-cell proliferation of the gastrointestinal tract in a patient with antigliadin antibodies but not celiac disease. Am J Surg Pathol. 2006;30(4):539-544. (Pubitemid 43740158)
97. Zamboni G, Franzin G, Scarpa A, et al. Carcinoma-like signet-ring cells in gastric mucosa-associated lymphoid tissue (MALT) lymphoma. Am J Surg Pathol. 1996;20(5):588-598. (Pubitemid 26129446)
98. Pan L, Diss TC, Cunningham D, Isaacson PG. The bcl-2 gene in primary B cell lymphoma of mucosa-associated lymphoid tissue (MALT). Am J Pathol. 1989;135(1 ):7-11. (Pubitemid 19228985)
99. El-Zimaity HMT, Wotherspoon A, de Jong D. Interobserver variation in the histopathological assessment of malt/malt lymphoma: towards a consensus. Blood Cells Mol Disease. 2005;34(1):6-16. (Pubitemid 40017974)
100. Hummel M, Oeschger S, Barth TFE, et al. Wotherspoon criteria combined with B cell clonality analysis by advanced polymerase chain reaction technology discriminates covert gastric marginal zone lymphoma from chronic gastritis. Gut. 2006;55(6):782-787. (Pubitemid 43764546)
101. Wotherspoon AC, Ortiz-Hildago C, Falzon MR, Isaacson PG. Helicobacter pylori-associated gastritis and primary B-cell gastric lymphoma. Lancet 338(8776):1175-1176, 1991.
102. Genta RM, Hamner HW, Graham DY. Gastric lymphoid follicles in Helicobacter pylori infection: frequency, distribution, and response to triple therapy. Hum Pathol. 1993;24(6):577-583. (Pubitemid 23162223)
103. ParsonnetJ, Hansen S, Rodriguez L, et al. Helicobacter pylori infection and gastric lymphoma. N Engl J Med. 1994;330(18):1267-1271. (Pubitemid 24129959)
104. Nakamura S, Yao T, Aoyagi K, lida M, Fujishima M, Tsuneyoshi M. Helicobacter pylori and primary gastric lymphoma: a histopathologic and immunohistochemical analysis of 327 patients. Cancer. 1997;79(1):3-11. (Pubitemid 26425501)
105. Nakamura S, Aoyagi K, Furuse M, et al. B-cell monoclonality precedes the development of gastric MALT lymphoma in Helicobacter pylori-associated chronic gastritis. Am J Pathol. 1998;152(5):1271-1279. (Pubitemid 28221879)
106. Zucca E, Bertoni F, Roggero E, et al. Molecular analysis of the progression from Helicobacter pylori-associated chronic gastritis to mucosa-associated lymphoid-tissue lymphoma of the stomach. N Engl J Med. 1998;338(12):804-810. (Pubitemid 28135987)
107. Zullo A, Hassan C, Christofari F, et al. Effects of Helicobacter pylori eradication on early stage gastric mucosa-associated lymphoid tissue lymphoma. Clin Gastroenterol Hepatol. 2010;8(2):105-110.
108. Wotherspoon AC, Doglioni C, Isaacson PG. Low grade gastric B-cell lymphoma of mucosa-associated lymphoid tissue (MALT): a multifocal disease. Histopathology. 1992;20(1 ):29-34.
109. Zucca E, Dreyling M; ESMO Guidelines Working Group. Gastric marginal zone lymphoma of MALT type: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2010;21(suppl 5):v175-v176.
110. Ruskone-Fourmestraux A, Fischbach W, Aleman BMP, et al. EGILS consensus report: gastric extranodal marginal zone B-cell lymphoma of MALT. Gut. 2011 ;60(6):747-758.
111. Ferrucci PF, Zucca E. Primary gastric lymphoma pathogenesis and treatment: what has changed over the past 10 years? Br J Haematol. 2006;136(4): 521-538. (Pubitemid 46148190)
112. Zullo A, Hassan C, Andriani A, et al. Treatment of low-grade gastric MALT-lymphoma unresponsive to Helicobacter pylori therapy: a pooled-data analysis. Med Oncol. 2010;27(2):291-295.
113. Copie-Bergman C, Gaulard P, Lavergne-Slove A, et al. Proposal for a new histological grading system for post-treatment evaluation of gastric MALT lymphoma [letter]. Gut. 2003;52(11):1656.
114. Savio A, Franzin G, Wotherspoon AC, et al. Diagnosis and posttreatment follow-up of Helicobacter pylori-positive gastric lymphoma of mucosa-associated lymphoid tissue: histology, polymerase chain reaction, or both? Blood. 1996; 87(4):1255-1260. (Pubitemid 26056888)
115. Thiede C, Wundisch T, Alpen B, et al. Long-term persistence of monoclonal B cells after cure of Helicobacter pylori infection and complete histologic remission in gastric mucosa-associated lymphoid tissue B-cell lymphoma. J Clin Oncol. 2001;19(6):1600-1609. (Pubitemid 32230859)
116. Wundisch T, Thiede C, Morgner A, et al. Long-term follow-up of gastric MALT lymphoma after Helicobacter pylori eradication. J Clin Oncol. 2005; 23(31):8018-8024. (Pubitemid 46657403)
117. Bertoni F, Conconi A, Capella C, et al. Molecular follow-up in gastric mucosa-associated lymphoid tissue lymphomas: early analysis of the LY03 cooperative trial. Blood. 2002;99(7):2541-2544. (Pubitemid 34525443)
118. Remstein ED, Kurtin PJ, James CD, Wang XY, Meyer RG, Dewald GW. Mucosa-associated lymphoid tissue lymphomas with t(11;18)(q21;q21) and mucosa-associated lymphoid tissue lymphomas with aneuploidy develop along different pathogenetic pathways. Am J Pathol. 2002;161(1):63-71. (Pubitemid 34760771)
119. Starostik P, Patzner J, Greiner A, et al. Gastric marginal zone B-cell lymphomas of MALT type develop along 2 distinct pathogenetic pathways. Blood. 2002;99(1):3-9. (Pubitemid 34532956)
120. Hamoudi RA, Appert A, Ye H, et al. Differential expression of NF-KB target genes in MALT lymphoma with and without chromosome translocation: insights into molecular mechanism. Leukemia. 2010,24(8): 1487-1497.
121. Rosenwald A, Ott G, Stilgebauer S, et al. Exclusive detection of the t(11;18)(q21;21) in extranodal marginal zone B cell lymphomas (MZBL) of MALT type in contrast to other MZBL and extranodal large B cell lymphomas. Am J Pathol. 1999;155(6):1817-1821.
122. Remstein ED, James CD, Kurtin PJ. Incidence and subtype specificity of API2-MALT1 fusion transcripts in extranodal, nodal, and splenic marginal zone lymphomas. Am J Pathol. 2000;156(4):1183-1188. (Pubitemid 30659996)
123. Rinaldi A, Mian M, Chigrinova E, et al. Genome-wide DNA profiling of marginal zone lymphomas identifies subtype-specific lesions with an impact on the clinical outcome. Blood. 2011;117(5):1595-1604.
124. Liu H, Ruskon-Fourmestraux A, Lavergne-Slove A, et al. Resistance of t(11;18) positive gastric mucosa-associated lymphoid tissue lymphoma to Helicobacter pylori eradication therapy [letter]. Lancet. 2001;357(9249):39-40. (Pubitemid 32056501)
125. Ye H, Liu H, Raderer M, et at. High incidence of t(11;18)(q21;q21) in Helicobacter pylori-negative gastric MALT lymphoma. Blood. 2003; 101 (7): 2547-2550. (Pubitemid 36857611)
126. Yeh KH, Kuo SH, Chen LT, et al. Nuclear expression of BCL10 or nuclear factor kappa B helps predict Helicobacter pylori-independent status of low-grade gastric mucosa-associated lymphoid tissue lymphoma with and without t(11;18)(q21;q21). Blood. 2005;106(3):1037-1041.
127. ToracchioS, Ota H, deJongD, et al. Translocation t(11;18)(q21;q21) in gastric B-cell lymphomas. Cancer Sci. 2009;100(5):881-887.
128. de Jong D, Boot H, van Heerde P, Hart GAM, Taal BG. Histological grading in gastric lymphoma: pretreatment criteria and clinical relevance. Gastroenterology. 1997; 112(5): 1466-1474. (Pubitemid 27181369)
129. Ferreri AJM, Freschi M, Dell'Oro S, Viale E, Ponzoni M. Prognostic significance of the histopathologic recognition of low- and high-grade components in stage I-II B-cell gastric lymphomas. Am J Surg Pathol. 2001;25(1):95-102. (Pubitemid 32001838)
130. Omonishi K, Yoshino T, Sakuma I, Kobayashi K, Moriyama M, Agaki T. bcl-6 protein is identified in high-grade but not low-grade mucosa-associated lymphoid tissue lymphomas of the stomach. Mod Pathol. 1998, 11(2):181-185. (Pubitemid 28144154)
131. O'Sullivan MJ, Ritter JH, Humphrey PA, Wick MR. Lymphoid lesions of the gastrointestinal tract: a histologic, immunophenotypic, and genotypic analysis of 49 cases. Am J Clin Pathol. 1998:110(4);471-477. (Pubitemid 28443440)
132. Owens SR, Smith LB. Molecular aspects of H pylori-related MALT lymphoma. Patholog Res Int. 2011;2011:193149.
133. Wang G, Auerbach A, Wei M, et al. t(11;18)(q21;q21) in extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue in stomach: a study of 48 cases. Mod Pathol. 2009, 22(1):79-86.
134. Burke JS, Sheibani K, Nathwani, BN, Winberg CD, Rappoport H. Monoclonal small (well-differentiated) lymphocytic proliferations of the gastrointestinal tract resembling lymphoid hyperplasia: a neoplasm of uncertain malignant potential. Hum Pathol. 1987;18(12):1238-1245. (Pubitemid 18018953)
135. Collins RD. Is clonality equivalent to malignancy: specifically, is immunoglobulin gene rearrangement diagnostic of malignant lymphoma? Hum Pathol. 1997;28(7):757-759.